PYC Therapeutics Director Buys Shares Ahead of AGM
PYC: $1.93 +4.32% · MC: $1.9B
PYC Therapeutics director Ian Constable bought shares on market through a family trust, increasing his indirect holding by about 16%. The purchase follows separate on-market acquisitions by directors Rohan Hockings and Peter Coleman in recent days. PYC also reminded shareholders that its AGM will be held next Thursday in Nedlands, Western Australia, with a Zoom option available through advance registration.

Comments